Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
21.67
Price to sales ratio
1.79

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4062
RLYB
Rallybio Corporation - Common Stock
15.89 USD+1.02%+0.19%-0.50%+3431.11%84.19 M USD
4086
ENTX
Entera Bio Ltd. - Ordinary Shares
1.64 USD-1.20%-4.65%+31.20%-7.34%80.73 M USD
4091
ACET
Adicet Bio, Inc. - Common Stock
8.55 USD-3.17%-6.35%+5.30%+1025.00%79.93 M USD
4095
HRTX
Heron Therapeutics, Inc. - Common Stock
0.42 USD+2.44%-2.33%0.00%-80.19%79.50 M USD

Frequently asked questions about Champions Oncology, Inc. - Common Stock

What is the Champions Oncology, Inc. - Common Stock stock price today?

The current price of Champions Oncology, Inc. - Common Stock (CSBR) is 5.8100000000000005. Over the past 24 hours, the stock has changed by -0.17%. Follow the CSBR chart for real-time price dynamics.

What is the stock ticker of Champions Oncology, Inc. - Common Stock?

Champions Oncology, Inc. - Common Stock trades under the ticker CSBR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Champions Oncology, Inc. - Common Stock stock going up?

CSBR has changed by +1.40% over the last week, -10.48% over the last month, and -27.83% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Champions Oncology, Inc. - Common Stock net income for the last quarter?

Champions Oncology, Inc. - Common Stock reported net income of -279 K for the last quarter. The previous quarter showed 268 K, which means net income changed by -204.10%.

How many employees does Champions Oncology, Inc. - Common Stock have?

As of the latest available data, Champions Oncology, Inc. - Common Stock has 306 employees. Workforce size can provide additional context about the company's scale and operations.

What is Champions Oncology, Inc. - Common Stock EBITDA?

Champions Oncology, Inc. - Common Stock EBITDA is -14.35 M, and its EBITDA margin is -87.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Champions Oncology, Inc. - Common Stock stock?

You can buy Champions Oncology, Inc. - Common Stock (CSBR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Champions Oncology, Inc. - Common Stock stock?

Investing in Champions Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSBR chart and related analysis on metatrader.com as part of your research.

News